The global landscape of tuberculosis (TB) diagnostics is undergoing a significant transformation following new recommendations issued by the World Health…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
In a recent clinical update, virologists Dr. Vincent Racaniello and Dr. Daniel Griffin expressed significant concern and bewilderment regarding proposed…
Read More
Paradigm Health Unveils AI-Powered Platform Revolutionizing Clinical Trial Execution
Paradigm Health is redefining the landscape of clinical research with its innovative, AI-powered platform designed to streamline the entire trial…
Read More
NYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AI
The pronouncement by Mitchell H. Katz, MD, President and CEO of NYC Health + Hospitals, the largest public healthcare system…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin
In his latest clinical update on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin, in conversation with Vincent…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A groundbreaking new longitudinal study, published April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Breath-Based VOC Analysis Emerges as a Rapid, Non-Invasive Frontier for Gut Microbiome Assessment and Early Disease Detection
A groundbreaking study led by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…
Read More
A Single Prenatal Toxic Exposure Linked to Multi-Generational Disease Risk, Paving Way for Epigenetic Diagnostics
New research emerging from Washington State University (WSU) has unveiled a groundbreaking understanding of disease inheritance, suggesting that a singular…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
A new population-based study, published in CANCER, a journal of the American Cancer Society, has brought into sharp focus a…
Read More
Insilico CEO Sees Potentially $2.75 Billion Collaboration as ‘Fusing Lilly’s Clinical Excellence’ with Insilico’s ‘End-to-End AI Engine’
On March 29, Insilico Medicine, a pioneer in artificial intelligence-driven drug discovery, announced a landmark collaboration with pharmaceutical giant Eli…
Read More
